Top

Published in:

Open Access 01-12-2016 | Question and Answer

World TB Day 2016: an interview with leading experts in tuberculosis research

Authors: Patrick P. J. Phillips, Helen A. Fletcher, Ibrahim Abubakar, Marc C. I. Lipman, Timothy D. McHugh

Published in: BMC Medicine | Issue 1/2016

Abstract

In this interview, we talk to leading tuberculosis (TB) experts from University College London and the London School of Hygiene and Tropical Medicine about the current challenges in TB research. The video of this interview is available here: https://www.youtube.com/watch?v=75Die7MQBec&feature=youtu.be. The video can also be downloaded via Additional file 1.

Available only for authorised users

Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, Mahomed H, McShane H; MVA85A 020 Trial Study Team. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet. 2013;381(9871):1021–8.CrossRefPubMed

Zak DE, Penn-Nicholson A*, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD., Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes J, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH., Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE., Walzl G, Aderem A, Hanekom WA, for other members of the ACS and GC6-74 cohort study teams. A prospective blood RNA signature for tuberculosis disease risk. Lancet. In Press.

Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, Matsumiya M, Tanner R, O’Shea MK, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Thomas Z-RM, Naranbhai V, Stylianou E, Darboe F, Penn-Nicholson A, Nemes E, Hatheril M, Hussey G, Mahomed H, Tameris M, McClain JB, Evans TG, Hanekom WA, Scriba TJ, McShane H. T cell activation is an Immune Correlate of Risk in BCG vaccinated infants. Nature Communications. In Press

Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, Pappas F, Phillips PP, Nunn AJ. the REMoxTB Consortium. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med. 2014;371(17):1577–87.CrossRefPubMedPubMedCentral

Jindani A, Harrison TS, Nunn AJ, Phillips PP, Churchyard GJ, Charalambous S, Hatherill M, Geldenhuys H, McIlleron HM, Zvada SP, et al. High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N Engl J Med. 2014;371(17):1599–608.CrossRefPubMedPubMedCentral

Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, Odhiambo J, Amukoye E, Bah B, Kassa F, et al. A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med. 2014;371(17):1588–98.CrossRefPubMed

Siroka A, Ponce NA, Lönnroth K. Association between spending on social protection and tuberculosis burden: a global analysis. [Epub ahead of print] Lancet Infect Dis. 2015. doi: 10.1016/S1473-3099(15)00401-6.

Yates TA, Khan PY, Knight GM, Taylor JG, McHugh TD, Lipman M, White RG, Cohen T, Cobelens FG, Wood R, Moore DA, Abubakar I. The transmission of Mycobacterium tuberculosis in high burden settings. Lancet Infect Dis. 2016;16(2):227–38. doi:10.1016/S1473-3099(15)00499-5. Epub 2016 Jan 26.CrossRefPubMed

WHO End TB Strategy http://www.who.int/tb/End_TB_brochure.pdf. Accessed 5 Mar 2016.

Title: World TB Day 2016: an interview with leading experts in tuberculosis research
Authors: Patrick P. J. Phillips
Helen A. Fletcher
Ibrahim Abubakar
Marc C. I. Lipman
Timothy D. McHugh
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Medicine / Issue 1/2016
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-016-0591-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

World TB Day 2016: an interview with leading experts in tuberculosis research

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

The impact of migration on tuberculosis epidemiology and control in high-income countries: a review

Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials

Frugal innovation in medicine for low resource settings

Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose–response meta-analysis of prospective cohort studies

Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy